Home

Hyper-accelerate drug and medical device development

Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to improve the safety of medical products and significantly cut R&D costs.

Who talks about us

Who talks about us

A revolution in
healthcare

Modeling & Simulation combined with artificial intelligence is the most effective way to innovate the R&D process in healthcare. Already successfully used for decades in many industrial sectors, this cutting-edge technology is finally about to revolutionize the medical industry. A computational approach can increase the safety while significantly reducing the development cost and the time to market of drugs and medical devices.

Your benefits

Icons/timer

Accelerate the development  of new drugs and medical devices

Icons/coins

Significantly cut R&D costs

Icons/safety

Improve the safety of medical products

Icons/flask

Reduce, refine and replace tests on animals and clinical trials

500+

Days faster than traditional approach

25%

Cost reduction

The Pursuit of Excellence in New Drug Development

Cutting R&D costs and
timeframes

We have built a unique cloud platform where powerful computational models, developed by top scientists at renowned universities, research centers and companies worldwide, are made available to the healthcare industry in an easy-to-use and cost-effective manner. Our game-changing approach to Modeling & Simulation means faster and way less expensive R&D for safer drugs and medical devices.

01.

Upload specific data and set parameters

02.

Run the simulation and get your outcomes

03.

Download your report in compliance with regulatory’s requirements

Icons/terminal

Our technology

Computational models combined with AI

We provide a series of cloud-based digital solutions that integrate computational models, so our clients do not need to worry about developing their own solutions and paying for very expensive software, IT infrastructures, and  specialized personnel. The cloud guarantees total data security and the possibility to access the platform from everywhere in the world.

"As simulation is now recommended by regulatory authorities and policy makers to accelerate approval without compromising with patient safety, it is essential to make available advanced simulation tools like ANSYS to the largest possible audience, no matter of their engineering simulation background. InSilicoTrials.com is the platform bridging the gap between software providers and clinical consumers."
Thierry Marchal
Program Director for Healthcare Solution

FROM THE BLOG

In Silico Talks - February 17, 2022

An interview with Giulia Russo

Our new guest on In Silico Talks today is Giulia Russo, Assistant Professor at the University of Catania, Italy, and…

Blog Section - April 20, 2021

How to accelerate the uptake of simulation in healthcare

NEWS AND PRESS RELEASES

Read our news and press releases

We are recognized as a major player in the Digital Twin & Biosimulations sector by 

We are part of part of Plug and Play’s Basel Accelerator Program

Start simulating now